There are close interactions between the adipocyte-derived hormone, leptin, and the anterior pituitary, especially the hypothalamic±pituitary±adrenal (HPA) axis. We investigated the relationship between the sympathetic adrenergic system and serum leptin levels, dependent on the function of anterior pituitary hormone axes, in 27 patients without a history of a hormone-secreting pituitary adenoma or other underlying endocrine disease. Based on responses in a routine insulin hypoglycemia test (ITT), the patients were classi®ed as hypopituitary (HP; n 15Y growth hormone de®cient (GHD; n 6 or controls (CTR; 6 patients with normal responses).
Introduction
Leptin, the ob-gene product, is a peptide hormone derived from adipocytes and is involved in the regulation of food intake (1) . However, expression at low levels has recently been demonstrated in other tissues (2, 3) . Plasma concentrations of leptin are positively correlated to body mass index (4), with higher levels in women than in men (5) .
Recently, a close relationship between leptin and the anterior pituitary endocrine axes has been demonstrated. Leptin levels are pulsatile and are inversely related to pituitary±adrenal function (6) , with a diurnal peak at around midnight (7, 8) . Glucocorticoids enhance leptin levels (9) , partially independent of alterations in total body fat mass (10) , while adrenocorticotropic hormone (ACTH) and central activation of the hypothalamic±pituitary±adrenal (HPA) axis does not alter plasma leptin concentrations acutely (11) . A functional leptin receptor has recently been demonstrated in human cortical and medullary adrenal tissue (12) . In physiological doses, growth hormone (GH) does not seem to alter serum leptin levels acutely (13, 14) and the circadian rhythm of leptin is preserved in GH de®cient (GHD) patients (15, 16) . Substitution with GH to GHD adults is followed by a decrease in leptin levels secondary to changes in body composition and reduced total body fat mass (17) . Estradiol and testosterone have complementary effects on leptin levels, resulting in the above mentioned gender differences (5) . The relationship between adipocyte-derived leptin and the hypothalamic±pituitary±thyroid axis is more complex due to interactions at several levels (18, 19) , and there are few studies addressing this question in pituitary disorders.
Similarly, current knowledge of the relationship between leptin and the sympathetic nervous system is still limited, and the results of recent research are controversial. Human plasma leptin concentrations are temporarily suppressed by infusion of the beta-adrenergic agonist isoprenaline (20, 21) . However, a corresponding effect could not be demonstrated for endogenous alterations in plasma catecholamines after treatment with a catecholamine synthese inhibitor (22) , and there is a lack of leptin suppression in patients with pheochromocytoma (23) . Furthermore, surgically induced acute stress response resulted in a rapid decrease in plasma leptin levels parallel to an increase in cortisol levels (24) .
In this study, we investigated (i) the physiological relationship between the sympathetic adrenergic system and serum leptin levels, and (ii) the dependence of these interactions on the proper function of the anterior pituitary. For this purpose, we evaluated patients with impaired pituitary function and compared them with patients with intact hormonal axes during acute, hypoglycemia-induced stress (insulin tolerance test ITT).
Subjects and methods

Subjects
We studied consecutive patients with suspected or proven pituitary disease. An ITT was performed as part of the routine assessment of pituitary function in all patients aged ,60 years, and without a history of epilepsy or cardiac disease n 59X Subjects with hormone-secreting pituitary adenoma (previously acromegaly n 10Y Cushing's disease n 6Y prolactinoma n 1 and thyrotropin secreting adenoma n 1 were excluded, as were subjects with other underlying endocrine or metabolic disorders (1 patient with primary hyperparathyroidism and 1 with primary hyperaldosteronism, 2 patients with diabetes mellitus) and patients with inadequate hypoglycemia (plasma glucose $2.2 mmol/l; n 6X The ITTs of the remaining 31 patients were analyzed for the maximal responses in the somatotrope and corticotrope hormone affected axes, according to the following de®-nition: GH ,10 mU/l and/or cortisol ,500 nmol/ impaired response. Patients with normal GH response but impaired cortisol response n 4 were not analyzed further because of the low number of individuals in this group. The remaining 27 patients were divided into three groups: (i) hypopituitary (HP), patients with impaired responses in both the somatotrope and corticotrope hormone axes n 15Y (ii) growth hormone de®cient (GHD), patients who had impaired responses in the somatotrope axis but normal responses in the corticotrope axis n 6Y and (iii) controls (CTR), patients who had normal responses in both axes n 6 ( Table 1 ). There were no signi®cant differences in body mass index (BMI) or gender between 
Methods
An insulin tolerance test was performed at 0900 h after a 10-h overnight fast as part of the routine assessment of pituitary function. The patients were recumbent for 30 min after intravenous cannulation. The cannula was kept patent with heparinized saline. An i.v. bolus injection of insulin (Insulin Actrapid, Novo Nordisk, Ru È d, Norway; 0.10±0.15 IU/kg body weight) was then given at time 0 and the test was terminated after 90 min with a soft drink and a substantial meal. Blood samples were taken every 15 min from 0 to 90 min, and at the time when each patient had symptoms of hypoglycemia (H). Nadir plasma glucose was ,2.2 mmol/l in all subjects. The blood samples were analyzed for glucose, ACTH, cortisol, GH, leptin, and plasma catecholamines (CA; norepinephrine (NE) and epinephrine (E)). Serum samples were collected in tubes without anticoagulant, allowed to clot and centrifuged at 3000 r.p.m. for 10 min at room temperature. Serum was decanted, aliquots were frozen at 220 8C until further use. Plasma samples were collected on ice into EDTA containing tubes (for ACTH analysis) or gluthation-EGTA tubes (for CA analysis), centrifuged at 4 8C at 3000 r.p.m. for 10 min and rapidly frozen at 220 8C and 280 8C for ACTH and CA respectively until assayed. In all subjects, 24-h urine sampling was performed the day prior to ITT.
Biochemical measurements
Catecholamine concentrations were assayed by high performance liquid-chromatography (HPLC) with a reverse phase column and a glassy carbon electrochemical detector (Waters, Milford, MA, USA), using a commercial kit from Chromsystems, Mu È nchen, Germany. In our hands, the intra-and interassay variations were, respectively, 10.7% and 14.5% for NE, and 23.2% and 10.5% for E.
Cortisol, ACTH, GH and leptin were determined by RIA (cortisol: Orion Diagnostica, Epsoo Finland; GH: Pharmacia, Uppsala, Sweden; ACTH: Nichols Institute, Nijmegen, The Netherlands; leptin: Linco Research Inc., St Charles, MO, USA). Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were measured by immunoassay (Access, Beckman Instruments, Chaska, MN, USA) while thyrotropin (TSH), free thyroxine (FT 4 ) and testosterone were measured by time-resolved¯uoroimmunoassay (Wallac Oy, Turku, Finland). Estradiol was measured by Microparticle Enzyme Immunoassay (Abbott Laboratories, Abbott Parl, IL, USA). Plasma glucose was measured during the ITT with Accutrend Sensor Glucose Stix and the values were veri®ed with a photometric hexokinase method, Hitachi 917 (F Hoffman-La Roche Ltd, Basel, Switzerland).
Statistics
When comparing three groups of individuals, one-way ANOVA was followed by Scheffe's post hoc test for statistical signi®cance. In the paired situation, multiple analyses of variance (ANOVA) were performed a Á priori and, if signi®cant, a paired sample t-test was performed a Á posteriori. Relations between variables were tested using Pearson's correlation test and the Figure 1 Insulin tolerance test: responses of plasma concentrations of glucose, epinephrine and norepinephrine in patients with hypopituitarism (HP), GH de®ciency (GHD), and controls (CTR). The P value in the upper right corner denotes the signi®cance of the interaction between group and time from the ANOVA test. Data are given as means^S.E.M. *P , 0X05Y **P , 0X01 compared with baseline; #P , 0X05 compared with controls; ²P , 0X01 compared with HP. H=time of hypoglycemia.
Leptin and endogenous catecholamines level of statistical signi®cance was chosen as P , 0X05 (two-sided) for all tests. Multiple regression analysis was performed to evaluate the in¯uence of FT 4 , BMI and gender on leptin levels. Data are given as means^S.E.M. if not otherwise quoted.
Results
Plasma glucose
After an i.v. bolus injection of insulin, plasma glucose levels fell beneath the de®ned hypoglycemia threshold of 2.2 mmol/l in all groups (Fig. 1) , with a nadir of 1.5^0X1 mmolal after 21.5^1X5 min in GHD, 24.7^1X1 min in HP, and 27.8^1X4 min in CTR patients. There was a signi®cant difference between hypoglycemia (H) in the GHD and CTR groups P , 0X02X
ACTH, cortisol, GH and insulin-like growth factor-I (IGF-I)
According to our de®nition of the three groups, 24-h excretion of cortisol, basal serum cortisol levels, and stimulated cortisol and ACTH levels were signi®cantly lower in subjects with HP compared with both GHD and CTR patients (Tables 2 and 3) , as were serum IGF-I and basal GH levels in GHD compared with CTR patients. Stimulated GH levels were signi®cantly lower in both HP and GHD subjects compared with CTR (Table 3) .
Catecholamine levels
Plasma epinephrine levels rose signi®cantly from basal levels in all groups at the time of hypoglycemia (H) (Fig. 1) ; the greatest response was seen in the GHD group, reaching levels that were signi®cantly higher than in HP patients P , 0X01X The D-values at the time of hypoglycemia were signi®cantly different between the groups (1.781^0X493 vs 6.0661 X633 nmolal for HP and GHD respectively; P , 0X01X The rise in plasma norepinephrine was delayed in the HP and CTR groups (60 min) and was of a lesser degree compared with the rise in epinephrine (Fig. 1) , while the maximum rise in the GHD group was seen at the time of hypoglycemia, reaching signi®cantly higher levels than in both the CTR P , 0X05 and HP groups P , 0X01X The D-values at the time of hypoglycemia *P , 0X05Y **P , 0X01Y compared with baseline; ²P , 0X05Y ²²P , 0X01Y ²²²P , 0X001Y HP compared with at the same timepoint; #P , 0X05 CTR compared with at the same timepoint.
were also signi®cantly different in the GHD (3.563^0X975 nmolal compared with CTR (0.7060 X508 nmolalY P , 0X05 and HP groups (0.4390 X361 nmolalY P , 0X001X
Leptin levels
Basal leptin levels were not signi®cantly different between the groups. When correcting basal leptin levels for gender, BMI and FT 4 using a multiple regression model, no differences were found for basal leptin levels between the groups. Forty-®ve minutes after an i.v. bolus injection of insulin, there was a signi®cant decrease in serum leptin levels in HP patients (24.7^2X5%Y P , 0X05Y which was maintained after 60 min (25.6^2X5%Y P , 0X05X In CTR patients, there was a signi®cant decrease in serum leptin levels 60 min after i.v. insulin (214.4^6X9%Y P , 0X05X No signi®cant response was observed in the GHD group; however 5 of 6 patients had decreased levels at 45 and 60 min (Fig. 2) . When expressed in absolute values, and as a percentage decrease in serum leptin concentration, no differences between the groups over time were found (Figs 1 and 2) . When normalized to BMI and expressed as leptin/BMI ratio (ng/ml/ kgÂm 2 ), similar results were obtained (data not shown).
Discussion
This study demonstrates for the ®rst time the physiological effect of an endogenous catecholamine release on serum leptin levels in humans, investigated in subjects with distinct anterior pituitary function. Epinephrine is principally produced by the adrenal medulla, whereas circulating norepinephrine is released almost exclusively by the sympathetic nerves (25) . In the present study, in HP and CTR patients the increase in norepinephrine was delayed and was of considerably lower magnitude compared with the epinephrine response, which had its maximum at the time of hypoglycemia. This is in accordance with earlier investigations on the insulin-induced stress response in healthy subjects (26) . However, patients with isolated GHD had their signs and symptoms of hypoglycemia signi®cantly earlier than controls, with a faster and more pronounced norepinephrine increase that accompanied the epinephrine increase; both responses were signi®cantly higher than in the HP and CTR groups. These ®ndings need to be elucidated with further studies.
In contrast with a recent investigation on stress response during surgery (24), we observed a signi®cant negative effect on serum leptin levels 20 min after the onset of hypoglycemia, i.e. before the maximum cortisol increase. This suggests that principally adrenergic mechanisms and not alterations in the HPA axis are responsible for the decrease in serum leptin levels during acute endogenous stress. The activation of beta 3 receptors in the adipose tissue by epinephrine has been discussed as a possible mechanism (27±30).
Leptin levels have been shown to be inversely related to the HPA axis (6) . In the present study, however, there were no obvious differences between patients with HP and isolated GHD or CTR, with regard to the decrease in serum leptin levels after catecholamine release. In accordance with this, a recent investigation did not demonstrate acute effects of a naloxone-induced ACTH release on plasma leptin levels (11) . Further, the present data do not show divergent leptin responses between subjects with normal growth hormone responses (CTR) and patients with GHD or HP. This indicates that GH has no acute effects on short-term leptin regulation, as found by others (13, 15) . We therefore suggest that the sympathetic adrenergic system might have an important role in the shortterm regulation of leptin levels in man, independent of anterior pituitary function.
The present study was designed as a pilot study and blood samples were obtained according to our routines for the ITT. Plasma catecholamines were determined at the moment of clinical signs and symptoms of hypoglycemia, with an average glucose nadir as low as 1.5 mmol/l, which warranted a maximum stress response. Hypoglycemic symptoms arose signi®cantly earlier in the GHD group compared with controls. As the objective was merely to demonstrate an adequate adrenergic response to ITT, as shown in earlier studies (26) , catecholamine measurements were not obtained at close enough intervals to permit conclusions about possible differences in responses between the groups. Thus, the lower epinephrine peak in patients with HP might re¯ect either an asynchronous (accelerated or postponed) epinephrine response in this group Leptin and endogenous catecholamines compared with patients with GHD, or indicate a real difference in stress responses, dependent on anterior pituitary function. However, to elucidate the underlying mechanism, a study design with more frequent blood samples would be necessary.
Finally, as an interesting clinical aspect, patients with HP, although supposed to be adequately substituted in the thyrotrope hormone axis, had signi®cantly lower free thyroxine levels within the normal range, compared with patients with isolated GHD and controls. This emphasizes the problem of determining optimal substitution doses based on clinical and laboratory assessment (31) .
Conclusions
(i) An acute increase in endogenous circulating catecholamines is associated with a rapid decrease in serum leptin levels. (ii) Intact anterior pituitary function does not seem to be essential for this hitherto poorly understood mechanism.
